Response to Re: Naftopidil vs silodosin in medical expulsive therapy for ureteral stones: A
randomized controlled study in Japan Page 1 Letter to the Editoriju_3002 792..793 Re …

Re: Naftopidil vs silodosin in medical expulsive therapy for ureteral stones: A randomized
controlled study in Japanese male pat Page 1 Letter to the Editoriju_3002 792..793 Re …

The aim of the present study was to compare the efficacy of the selective α1D‐adrenoceptor
antagonist naftopidil and the selective α1A‐adrenoceptor antagonist silodosin (as an …

I read with great interest an article published by Ramadhani et al.[1] in the latest edition of
the Journal. In this study, the authors have performed a systematic review and meta-analysis …

Purpose A multicenter, double-blind, randomized, controlled trial was conducted to
determine the efficacy of naftopidil as medical expulsive therapy (MET) for patients with …

Purpose: Naftopidil is a specific α1D-adrenergic receptor antagonist. We performed the
current randomized, controlled study to determine the expulsive role of naftopidil for distal …

Purpose To compare the safety and efficacy of naftopidil and tamsulosin with prednisolone
as medical expulsive therapy for distal ureteric stones. Materials and Methods Between July …

Introduction The aim of this study was to compare the safety and efficacy of silodosin (8 mg)
versus tamsulosin (0.4 mg) as a medical expulsive therapy for distal ureteral stones …

Purpose To compare the efficacy of α 1 D-receptor antagonist Naftopidil and α 1 A/D-
receptor antagonist Tamsulosin in management of distal ureteral stones. Materials and …

Purpose: We aimed to investigate the efficacy of silodosin 4 mg/day and 8 mg/day for
medical expulsive therapy (MET) of lower ureteral stones. Materials and Methods: We …